CAR T cells secreting NGF-neutralizing scFv enhance efficacy in clear cell renal cell carcinoma by relieving immunosuppression through immunosympathectomy
Background Chimeric antigen receptor (CAR) T cells have demonstrated remarkable breakthroughs in treating hematologic malignancies, yet their efficacy in solid tumors is limited by the immunosuppressive microenvironment. Sympathetic nerves significantly contribute to this immunosuppressive milieu in...
Saved in:
| Main Authors: | Meng Li, Xi Chen, Lan Wang, Peiwei Yang, Fan Yu, Zongke Bai, Hanmei Xu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-12-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/12/12/e009910.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
scFv Antibody: Principles and Clinical Application
by: Zuhaida Asra Ahmad, et al.
Published: (2012-01-01) -
Screening and characterization of the scFv for chimeric antigen receptor T cells targeting CEA-positive carcinoma
by: Chengcheng Zhang, et al.
Published: (2023-05-01) -
Corrigendum: Screening and characterization of the scFv for chimeric antigen receptor T cells targeting CEA-positive carcinoma
by: Chengcheng Zhang, et al.
Published: (2025-01-01) -
Exploring the Biological Activity of a Humanized Anti-CD99 ScFv and Antibody for Targeting T Cell Malignancies
by: Nuchjira Takheaw, et al.
Published: (2024-11-01) -
Discovery and in vitro characterization of a human anti-CD36 scFv
by: Cecilia Mata-Cruz, et al.
Published: (2025-02-01)